Cargando…
Pharmacological targeting of cognitive impairment in depression: recent developments and challenges in human clinical research
Impaired cognition is often overlooked in the clinical management of depression, despite its association with poor psychosocial functioning and reduced clinical engagement. There is an outstanding need for new treatments to address this unmet clinical need, highlighted by our consultations with indi...
Autores principales: | Colwell, Michael J., Tagomori, Hosana, Chapman, Sarah, Gillespie, Amy L., Cowen, Philip J., Harmer, Catherine J., Murphy, Susannah E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671959/ https://www.ncbi.nlm.nih.gov/pubmed/36396622 http://dx.doi.org/10.1038/s41398-022-02249-6 |
Ejemplares similares
-
An online experimental medicine trial on the effect of 28-day simvastatin administration on emotional processing, reward learning, working memory and salivary cortisol in healthy volunteers at risk for depression: OxSTEP protocol
por: Waters, Shona, et al.
Publicado: (2023) -
A single dose of fluoxetine reduces neural limbic responses to anger in depressed adolescents
por: Capitão, Liliana P., et al.
Publicado: (2019) -
Acute neural effects of fluoxetine on emotional regulation in depressed adolescents
por: Capitão, Liliana P., et al.
Publicado: (2023) -
Translating the promise of 5HT(4) receptor agonists for the treatment of depression
por: Murphy, Susannah E, et al.
Publicado: (2021) -
The pharmacological bases for repurposing statins in depression: a review of mechanistic studies
por: De Giorgi, Riccardo, et al.
Publicado: (2023)